HKHuanmin Kang

Huanmin Kang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Huanmin Kang has a total of 22 co-authors. Here are the top co-authors by number of shared publications:

  • Yan He

    Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmic and Visual Science Key Laboratory, Beijing, China

    8 shared publications
  • Yingyi Liu

    Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmic and Visual Science Key Laboratory, Beijing, China

    8 shared publications
  • Yuerong Ren

    Department of Ophthalmology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China; Hunan Clinical Research Center of Ophthalmic Disease, Changsha, Hunan 410011, China

    7 shared publications
  • Jing Tian

    Department of Rheumatology and Immunology, The Second Xiangya Hospital, Central South University, Changsha, China

    6 shared publications
  • Jianing Feng

    Xi’an People’s Hospital (Xi’an Fourth Hospital), Shaanxi Eye Hospital, Northwest University Affiliated People’s Hospital, Xi’an, China

    5 shared publications
  • Wen Shi

    Department of Ophthalmology, The Second Xiangya Hospital, Central South University, Changsha, China

    5 shared publications

Latest Publications

  • Open Access

    Evaluation and correlation analysis of ocular surface involvement and systemic conditions in patients with rheumatoid arthritis

    by Xiang Li, Yingyi Liu, Huanmin Kang, Jing Tian, Ying Jie, Yan He

    Rheumatoid arthritis (RA) is a systemic autoimmune disease in which ocular surface involvement is common but often underrecognized. This study investigated ocular surface changes in patients with RA and their associations with systemic disease features. Twenty-one patients with RA and 25 age- and sex-matched non-disease controls were prospectively enrolled. Ocular surface symptoms and signs, conjunctival impression cytology, and multiplex tear cytokine profiles were assessed. In patients with RA, disease duration, disease activity, autoantibodies, and circulating inflammatory markers were collected and correlated with ocular findings. Public gene-expression datasets from RA synovium and peripheral blood were also analyzed. Dry eye disease (DED) occurred in 42.86% of eyes in patients with RA, predominantly of the mixed subtype. Compared with non-disease controls, patients with RA presented reduced reflex tearing, markedly lower conjunctival goblet cell density, and more severe ocular surface squamous metaplasia. Multiplex tear cytokine profiling revealed significantly increased levels of C-X-C motif chemokine ligand 11 (CXCL11) and interleukin-1β (IL-1β) in RA. Tear CXCL11 levels showed a suggestive positive correlation with IgA rheumatoid factor (RF). In publicly available transcriptomic datasets, CXCL11 expression was significantly elevated in RA synovial tissue from both large and small joints compared with that in osteoarthritic synovium. RA is frequently accompanied by DED and chronic ocular surface inflammation, potentially mediated by tear cytokines and chemokines, and is closely linked to systemic disease status and synovial inflammation. Routine ocular surface screening and combined topical and systemic anti-inflammatory therapy should be considered.

  • Open Access

    Tacrolimus prolongs corneal allograft survival and prevents dendritic cell infiltration in a myeloid-derived suppressor cell–dependent manner

    by Yingyi Liu, Yuerong Ren, Runxi Luo, Xiujuan Li, Limin Xie, Huanmin Kang, Yang Li, Xiaonan Dong, Yan He


  • Open Access

    Correlation among ocular surface changes and systemic hematologic indexes and disease activity in primary Sjögren’s syndrome: a cross-sectional study

    by Yan He, Jianing Feng, Wen Shi, Yuerong Ren, Yingyi Liu, Huanmin Kang, Jing Tian, Ying Jie

    To explore the relationship among ocular surface changes, systemic hematologic indexes, and disease activity in primary Sjögren’s syndrome patients. Thirty-three primary Sjögren’s syndrome patients and 36 healthy controls were recruited in this cross-sectional study. All participants underwent complete ocular surface testing, including dry eye symptoms and signs, tear multi-cytokine analysis, and conjunctival impression cytology (CIC). Multiple systemic hematologic indexes and disease activity were also evaluated, including autoantibodies, immune cells, the EULAR Sjögren’s Syndrome Patient Reported Index (ESSPRI), and the EULAR Sjögren’s Syndrome Disease Activity Index (ESSDAI). Primary Sjögren’s syndrome patients exhibited significant dry eye, severe conjunctivochalasis, decreased goblet cell density, and severe squamous epithelial on the ocular surface. Interferon-inducible T cell alpha chemoattractant (I-TAC), granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin (IL)-1β, IL-5, IL-8, IL-10, IL-13, IL-21, C-C motif chemokine ligand (CCL)4, interferon-gamma (IFN-γ), CCL20, and tumor necrosis factor-gamma (TNF-α) in the tear fluid of pSS patients changed significantly. Correlation analysis showed that anti-SSA was relevant to ocular surface disease index (OSDI) score, tear break-up time (TBUT), and meibomian gland secretion (MGS). CD8+ T cell percentages were relevant to TBUT and corneal fluorescein staining score (CFS). IL-8, IL-13, CCL4, and TNF-α were correlated with RF-IgA. IL-1β, CCL4, and TNF-α were correlated with CD8+ T cell counts. IL-5 and CCL20 were correlated with the ratio of helper T cells and suppressor T cells. Tear I-TAC, IL-8, CCL20, and TNF-α were significantly correlated with the ESSDAI of different domains. Our results revealed that the ocular surface changes in pSS patients were significantly correlated with systemic hematologic indexes and disease activity.


  • Open Access

    Evaluation of ocular surface inflammation and systemic conditions in patients with systemic lupus erythematosus: a cross-sectional study

    by Yuerong Ren, Jing Tian, Wen Shi, Jianing Feng, Yingyi Liu, Huanmin Kang, Yan He

    The cross-sectional study was designed to evaluate the association of ocular surface inflammation with systemic conditions in patients with systemic lupus erythematosus (SLE). The study enrolled 30 SLE patients and 30 controls. Ocular symptoms were evaluated using the Ocular Surface Disease Index (OSDI) questionnaire. Tear samples from all participants were collected for tear multi-cytokine and chemokine concentration analysis. All participants were assessed for dry eye disease (DED), including Schirmer I test, tear break-up time (TBUT), corneal fluorescein staining (CFS), meibomian gland secretion (MGS), lid-parallel conjunctival folds (LIPCOF), corneal clarity, and symblepharon. Besides, all participants were also examined for conjunctival impression cytology to measure the density of conjunctival goblet cells (CGCs). The peripheral blood indicators from SLE patients were also collected to measure the SLE-associated autoantibody specificities and systemic inflammatory indicators. Pearson and Spearman’s analysis were uesd to examine the correlation between tear cytokines, CGCs, DED-related indicators, and systemic conditions. The two groups were matched for age and gender in this study. 36.67% of eyes (11 in 30) of SLE patients and 13.33% of eyes (4 in 30) of controls were diagnosed with DED. OSDI scores, abnormal TBUT percentages, CFS percentages, and DED grading were all higher in SLE patients than in control group, while density of CGCs was lower. There were no significant differences in Schirmer I test, MGS, LIPCOF, corneal clarity, and symblepharon between SLE patients and controls. The levels of tear chemokine (C-X-C motif) ligand 11 (CXCL11) and cytokine interleukin-7 (IL-7) in patients with SLE were significantly higher than those in control group. Moreover, among SLE patients, the severity of DED and the level of tear chemokine CXCL11 were significantly positively correlated with SLE-associated autoantibody specificities. Dry eye and tear cytokines and chemokines-mediated ocular surface inflammation persist in SLE patients and are associated with systemic conditions. Therefore, it is necessary for patients with SLE to combine systemic and ocular assessments. SLE patients have higher OSDI scores, abnormal TBUT percentages, CFS percentages, DED grading, and lower density of CGCs compared to controls. SLE patients have higher levels of tear chemokine CXCL11 and cytokine IL-7 compared to controls. Among SLE patients, the severity of DED and the level of tear chemokine CXCL11 are significantly positively correlated with SLE-associated autoantibody specificities.


  • Evaluation of Dry Eye Severity and Ocular Surface Inflammation in Patients with Autoimmune Rheumatic Diseases

    by Yingyi Liu, Mengbo Wu, Yuerong Ren, Jianing Feng, Wen Shi, Huanmin Kang, Jing Tian, Yan He

    To evaluate dry eye severity and ocular surface inflammation in autoimmune rheumatic diseases (ARDs). Seventy-nine patients with ARDs were enrolled, including 26 patients with rheumatoid arthritis (RA), 33 patients with systemic lupus erythematosus (SLE), and 20 patients with primary Sjögren's syndrome (pSS). All patients underwent ocular surface evaluations, including ocular surface symptoms, signs, conjunctival impression cytology, and tear multicytokine detection. Systemic conditions, including disease duration, disease activity, and serological parameters, were also noted. SLE patients had the shortest disease duration, and nearly half of them had low disease activity, while RA patients and pSS patients had a relatively long disease duration, and approximately 90% of them had moderate or high disease activity. The incidence of dry eye and the levels of the proinflammatory tear cytokines in SLE were significantly lower than those in RA and pSS. However, ocular surface squamous metaplasia was more severe in SLE and pSS than in RA. Dry eye severity in all ARD patients was shown to be independent of disease activity, while Nelson's grades were positively correlated with disease duration in RA patients. Disease-related serological parameters were associated with tear proinflammatory cytokines in all ARD patients. Variable degrees of dry eye and immune-mediated ocular surface inflammation persist in different ARD patients. In addition to a well-known association between dry eye and pSS, dry eye is also commonly observed in SLE and RA patients. Therefore, there is a definite need for regular ophthalmologic evaluations and topical medications in all patients with ARDs.


  • Open Access

    Rapamycin antagonizes angiogenesis and lymphangiogenesis through myeloid-derived suppressor cells in corneal transplantation

    by Yuerong Ren, Xiaonan Dong, Yingyi Liu, Huanmin Kang, Lingling Guan, Yumin Huang, Xinqi Zhu, Jing Tian, Baihua Chen, Bing Jiang, et al.


  • Open Access

    Evaluation and correlation analysis of ocular surface disorders and quality of life in autoimmune rheumatic diseases: a cross-sectional study

    by Yuerong Ren, Jing Tian, Wen Shi, Jianing Feng, Yingyi Liu, Huanmin Kang, Baihua Chen, Yan He

    Objective: This cross-sectional study aimed to reveal the association between ocular surface disorders and psychological, physiological situations among autoimmune rheumatic patients. Methods: Ninety autoimmune rheumatic patients (180 eyes) hospitalized in the Department of Rheumatology, The Second Xiangya Hospital, Central South University and 30 controls (60 eyes) were enrolled in the study. All participants were assessed for ocular surface disorders including dry eye disease (DED) by the Ocular Surface Disease Index (OSDI) for symptoms evaluation, and slim lamp examinations for tear break-up time (TBUT), meibomian gland secretion, symblepharon and corneal clarity, Schirmer I test, corneal fluorescein staining (CFS), lid-parallel conjunctival folds (LIPCOF). Systematic conditions were evaluated using the Short Form 36-Health Survey (SF-36) for health-related quality of life, Hospital Anxiety and Depression Scale (HADS) for anxiety and depression, Health Assessment Questionnaire-Disability Index (HAQ-DI) for difficulties in activities of daily living, and Pittsburgh Sleep Quality Index (PSQI) for sleep quality. Pearson and spearman’s analysis were conducted to examine the relationship between systematic conditions and ocular surface conditions. Results: The analyses were controlled for age and sex. 52.22% of eyes (94 in 180) of autoimmune rheumatic patients and 21.67% of eyes (13 in 60) of controls were diagnosed with DED. The autoimmune rheumatic patients showed significant higher OSDI score, fewer basal tear secretion, more severe CFS and conjunctivochalasis than controls. There were no statistically significant differences in TBUT, meibomian gland secretion, symblepharon, and corneal clarity between the two groups. For systematic conditions, autoimmune rheumatic patients had significantly lower SF-36 scores, higher anxiety scores, and HAQ-DI scores than controls. No statistically significant differences were detected in depression scores and PSQI between the two groups. Among autoimmune rheumatic patients, OSDI scores were moderately correlated with quality of life, anxiety, depression and sleep quality. Conclusion: Factors including quality of life, anxiety, depression, and sleep quality are associated with ocular surface conditions, especially DED symptoms. Management of systemic conditions and psychotherapy should also be considered as part of the treatment among autoimmune rheumatic patients.


  • Evaluation of Dry Eye Severity and Ocular Surface Inflammation in Patients with Pemphigus and Pemphigoid

    by Jianing Feng, Yingyi Liu, Yuerong Ren, Wen Shi, Huanmin Kang, Yixin Tan, Ruifang Wu, Guiying Zhang, Yan He

    To evaluate ocular surface involvement, tear cytokine levels, and histopathological changes in pemphigus and pemphigoid patients.A total of 22 patients (15 pemphigus and 7 pemphigoids) and 21 non-d...